William F. Hahne
Nessuna posizione attualmente
Profilo
William F.
Hahne worked as an Executive Director of Clinical Research at Eisai, Inc. from 1997 to 2002.
He then served as a Vice President of Medical at Vion Pharmaceuticals, Inc. After that, he held the position of VP of Clinical Development & Medical Affairs at Imunon, Inc. from 2006 to 2007.
Prior to that, he was a Vice President of Clinical Development at CuraGen Corp.
from 2003 to 2005.
He also worked as a Vice President of Clinical Development at CuraGen Corp.
and as a Vice President of Clinical Research at Bio-Path Holdings, Inc. Dr. Hahne completed his undergraduate degree at Grinnell College and obtained a doctorate degree from Cornell University.
Precedenti posizioni note di William F. Hahne
| Società | Posizione | Fine |
|---|---|---|
| IMUNON, INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2007 |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Direttore Tecnico/Scientifico/R&S | 01/01/2005 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Direttore Tecnico/Scientifico/R&S | 01/01/2002 |
| BIO-PATH HOLDINGS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Vion Pharmaceuticals, Inc.
 Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di William F. Hahne
| Cornell University | Doctorate Degree |
| Grinnell College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| IMUNON, INC. | Health Technology |
| BIO-PATH HOLDINGS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
- Borsa valori
- Insiders
- William F. Hahne
